Serum fibrosis biomarkers predict death and graft loss in liver transplantation recipients

E-ISSN： 1527-6473|21|11|1383-1394

ISSN： 1527-6465

Source： LIVER TRANSPLANTATION, Vol.21, Iss.11, 2015-11, pp. : 1383-1394

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Use of model for end‐stage liver disease exceptions for donation after cardiac death graft recipients relisted for liver transplantation

LIVER TRANSPLANTATION, Vol. 21, Iss. 4, 2015-04 ,pp. : 554-560

John Wiley & Sons Inc

Access to resources Recommend Favorite

Living donor liver transplantation using a graft with periportal fibrosis

HEPATOLOGY RESEARCH, Vol. 45, Iss. 12, 2015-12 ,pp. : 1248-1250

John Wiley & Sons Inc

Access to resources Recommend Favorite

Donation after cardiac death liver transplantation: Graft quality evaluation based on pretransplant liver biopsy

LIVER TRANSPLANTATION, Vol. 21, Iss. 6, 2015-06 ,pp. : 838-846

John Wiley & Sons Inc

Access to resources Recommend Favorite

The common I148 M variant of PNPLA3 does not predict fibrosis progression after liver transplantation for hepatitis C

HEPATOLOGY, Vol. 54, Iss. 4, 2011-10 ,pp. : 1483-1484

John Wiley & Sons Inc

Access to resources Recommend Favorite

TE predicts liver fibrosis of CHB in China

JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY, Vol. 30, Iss. 4, 2015-04 ,pp. : 756-762

John Wiley & Sons Inc

Access to resources Recommend Favorite